AG00HATB

106463-17-6 | Tamsulosin Hydrochloride

AG00HATB

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	106463-17-6
Catalog Number	AG00HATB(AGN-PC-07Y4WF)
Chemical Name	Tamsulosin Hydrochloride
IUPAC Name	5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride
InChI	InChI=1S/C20H28N2O5S.ClH/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24;/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24);1H/t15-;/m1./s1
InChI Key	ZZIZZTHXZRDOFM-XFULWGLBSA-N
MDL Number	MFCD00922997
Molecular Formula	C20H29ClN2O5S
Molecular Weight	444.9727
SMILES	O=S(C1=CC(C[C@H](NCCOC2=CC=CC=C2OCC)C)=CC=C1OC)(N)=O.[H]Cl
UNII	11SV1951MR
Synonyms	5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide, Flomax, LY 253352, LY-253352, tamsulosin, tamsulosin hydrochloride, YM 617, YM-617, TAMSULOSIN HYDROCHLORIDE, 106463-17-6, Tamsulosin HCl, Omnic, Flomax, Pradif, Amsulosin hydrochloride, Urolosin, Secotex, Josir, Alna, Omic, Omix, Expros, Harnal, Tamsulosin (hydrochloride), YM 617, UNII-11SV1951MR, (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride, LY253351, R-(-)-YM-12617, YM617, MFCD00922997, CHEBI:9399, YM-12617-1, 11SV1951MR, R-(-)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride, (-)-(R)-5-(2-((2-(o-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride, LY-253351, Flomax (TN), YM-617, Amsulosin Hydrochloride;Tamsulosin hydrochloride, DSSTox_CID_26628, DSSTox_RID_81777, DSSTox_GSID_46628, Q-201777, (R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide hydrochloride, 5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride, Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (R)-, CAS-106463-17-6, NCGC00167442-01, Yutanal, tamsulosin.HCl, Harnalidge OCAS, Flomax MR, AlnaOCAS, 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide hydrochloride, AK124398, Flomax hydrochloride, Harnal (TN), Tamsulosin hydrochloride [USAN:JAN], AC1NSFXI, PubChem18241, Tamsulosin-hydrochloride, Tamsulosin hydrochloride [USAN:USP:JAN], tamsulosine hydrochloride, Tamsulosina hydrochloride, Tamsulosinum hydrochloride, (-)-LY 253352, C20H29ClN2O5S, SCHEMBL23428, (R)-Tamsulosin Hydrochloride, C20H28N2O5S.HCl, Tamsulosin Hydrochloride,(S), MLS003899197, CHEMBL1200914, DTXSID2046628, HY-B0661A, 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride, ZZIZZTHXZRDOFM-XFULWGLBSA-N, KS-00000H3T, Tox21_112446, BG0475, EU-617, s4729, AKOS015895342, AKOS015995287, Tox21_112446_1, API0001417, BS-1019, CS-2897, MP-0769, RTX-011084, Tamsulosin hydrochloride (JP17/USAN), (-)-ly253352, 5-[(R)-2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride, NCGC00167442-03, AN-10809, CC-34638, H991, LS-31577, SC-17028, SMR002543366, BCP0726000042, Tamsulosin hydrochloride, >=98% (HPLC), AB0013408, FT-0631038, FT-0674803, ST24026438, Y-617, YM 12617-1, A14936, D01024, 463T176, I14-8827, (R)-(-)-YM12617;LY253351, (R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2, Tamsulosin hydrochloride, British Pharmacopoeia (BP) Reference Standard, Tamsulosin hydrochloride, European Pharmacopoeia (EP) Reference Standard, (R)-5-(2-((2-(2-ETHOXYPHENOXY)ETHYL)AMINO)PROPYL)-2-METHOXYBENZENESULFONAMIDE HCL, 5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-benzenesulfonamide hydrochloride, 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide hydrochloride, 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide hydrochloride, Tamsulosin hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Tamsulosin hydrochloride, United States Pharmacopeia (USP) Reference Standard, (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride, 2-methoxy-5-[3,3,3-trideuterio-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]benzenesulfonamidehydrochloride, 5-[(2R)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride, Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-,monohydrochloride, (R)-, dl-Tamsulosin hydrochloride, C20H28N2O5S.ClH, C20-H28-N2-O5-S.Cl-H, -methoxybenzenesulfonamide hydrochloride, ACN-048288, CB10238, CID5362376, CS-T-61586, T2749, 80223-99-0, Tamsulosin hydrochloride, 98%, Potent, selective alpha1A antagonist - 100MG 100mg, 128332-25-2,

Complexity	539
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	444.149g/mol
Formal Charge	0
Heavy Atom Count	29
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	444.971g/mol
Monoisotopic Mass	444.149g/mol
Rotatable Bond Count	11
Topological Polar Surface Area	108A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P280a-P304+P340-P405-P501a-P261-P305+P351+P338-P301+P312+P330
UN Code

Certificate of Analysis

Lot Number